Infleunza Part2 Wk4 Flashcards

You may prefer our related Brainscape-certified flashcards:
1
Q

Transcription of virus mRNAs use fragment of cellular mRNA
Cellular mRNA transcription

A
  • rapid addition of 5’ universal gap
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Influenza virus polymerase complex is bound to every genome segment

A

PB2 protein binds the 5’-cap of cellular mRNA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

PB1 & PA proteins work in concert as an endonuclease

A

= cleaves capped RNA (~10-15nt from the cap)
cap snatching

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Influenza virus polymerase complex

A

PB1 binds to both
-mRNA fragment with 5’-cap
-3’-end of genomic vRNA
=polymerase function

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

PB1 protein transcribes (+)ssRNA using

A

-mRNA fragments (with 5’-cap) as a primer
-genomic vRNA as a template

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

On reaching 5’end of vRNA template
(=3’end of the new (+)RNA)

A

The PB1 polymerase produces a polyA tail by reiterative stuttering
=repeated transcription on a short polyUTP sequence in the vRNA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Results of transcription = capped, polyadenylated chimeric mRNAs

A

5’-region is a fragment of cellular mRNA
Remainder is (+)ssRNA copy of (-)vRNA
5’-cap & polyA tail promote
-exit from cell nucleus
-translation by cell ribosomes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Influenza A virus replication cycle - genome replication
Is also RNA transcription but doesnt involve cap-snatching

A

Free rNTPs bind to the 3’-end of each of the cRNAs
PB1 polymerase protein forms a phosphodiester bond
PB1 transcribes (-)ssRNA from this dinucleotide primer
No 5’-cap is added - this is cRNA, not mRNA
(+) sense cRNA intermediates associated with with NP and polymerase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

A virus replication cycle - assembly & genome packaging
vRNAs & cRNAs associate with PB1, PB2, PA & NP in nucleus

A

Only vRNPs exit the nucleus - mediated through binding with M1 & NS2 proteins
M1 interacts with structual virus proteins at the plasma membrane
Plasma membrane & matrix layer wrap around vRNPs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Random / selective incorporation model

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Influenza A replication cycle - budding release

A

Exit by budding - gains envelops
Neuraminidase cleaves bonds
Also prevents virion aggregation
HA on new virions binds neuraminidase acids
On other virions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Neuraminidase protein is a targets for antiviral drugs

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Influenza virus pathogenesis
Acut, contagious infections of upper respiratory tract

A

-virus shed into respiratory lumen
-no systemic spread
-immune pathology
-self-limiting (strong immunity)
Fatalities rare
-elderly, young, immune-compromised
-viral / bacterial pneumonia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Influenza virus epidemics and pandemics

A

Seasonal recurrence of flu epidemics
-pandemic outbreaks also recorded through history

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Influenza A virus genetic diversity, change + exchange

A

Advantageous mutations in human influenza/avian or swine influenza virus strains = new combinations of genome segments between human, avian & swine influenza virus strains.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Antigenic drift -selection due to immune pressure
Advantageous mutations occur over time, driving immune resistance

A

Protein antibody response. outcome
HA neutralising block infection, protective
NA non-neutralising. ADCC, curtail infection
M2, NP non- neutralising ADCC curtail infection, protective

17
Q

Antigenic drink - cause of 1918 pandemic and 2013 outbreak

A

1918 H1N1 - avian virus HA mutations = expanded binding to a-2,6 AND a-2,3 galactose-sialic acid
2013 H7N9 - HA and PB2 mutations allow binding & efficient replication in human cells

18
Q

Antigenic shift- reassortment of genome fragments

A

Influenza A viruses infect humans, mammals + birds
-miltiple virus types can infect individual hosts
-mixing of human, avian and swine virus genomes occurs
Significant intermediate (mixing) hosts = pigs, domestic birds, waterfowl

19
Q

Antigenic shift - reassortment of genome fragments

A

-2 or more virus subtypes infect single cell
-both/all virus genomes replicate in same nucleus
= assembly of virions
-mixed packaging of genome segments from each original virus
= reassortment / antigenic shift
Novel combinations of virus genomes = reassortants
H/N combinations significant

20
Q

Antigenic shift = cause of 1957 pandemic

A

Antigenic drift of avian H1N1 virus
Humanised over several decades
1957 pandemic = reassortment with avian H2N2 virus
New HA, NA, PB1

21
Q

Antigenic shift = cause of 1968 pandemic

A

1957 H2N2 virus = reassortment with avian
H2 virus
(New HA, PB1)
(Same NA2)

22
Q

Antigenic shift = cause of 2009 “swine flu” outbreak

A

First reassortment
=triple reassortment between avian, swine H1N1 & the 1968 H3N2 Hong Kong viruses

23
Q

Second reassortment

A

Between “new” swine H3N2 (triple reassortment) with classical swine H1N1

24
Q

Third assortment

A

Reassortment with the “new” swine H1N2 & another H1N1 swine virus

25
Q

Antigenic shift= cause of 2013 “bird flu” outbreak

A

H7N9 reassortment involving
3 avian viruses
Exchange steps unknown
Domestic ducks H7N3 - wild birds H7N9 - domestic poultry Multiple H9N2 viruses

26
Q

Influenza A vaccines

A

Annual - rely on year-round, world-wide surveillance of subtypes
WHO- global influenza program
CDC - us influenza surveillance report
UDCD - European influenza surveillance network
North hemisphere feb
South hemisphere sep

27
Q

Flucelvax (Novartis)

A

Whole virus (inactivated)
Prepared in cell cultures
Injection formulation

28
Q

Flublok (Protein Sciences)

A

Recombinant HA protein
HA gene cloned into baculovirus
Prepared in infected insect cell cultures

29
Q

Flumist (Medimmune / Astra Zeneca)

A

Attenuated “live” virus
Prepared in infected hens eggs and chick cell cultures

30
Q

Multitalented nucleoside-modified mRNA vaccine against all known influenza virus subtypes

A

20 strains represented mRNA vaccine - HA antigens
Vaccination led to
Antibody development against all 20 strains in mice & ferrets
Reduced symptoms after lethal virus challenge
Increase survival after lethal virus challenge